Claudio Gasperini
Overview
Explore the profile of Claudio Gasperini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
194
Citations
3294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Aiello A, Ruggieri S, Navarra A, Tortorella C, Vanini V, Haggiag S, et al.
Vaccines (Basel)
. 2024 Aug;
12(8).
PMID: 39204049
This study investigated the incidence and severity of SARS-CoV-2 breakthrough infections (BIs) and the time to swab reversion in patients with multiple sclerosis (PwMS) after the booster dose of COVID-19...
12.
Giancola M, Haggiag S, Corpolongo A, Stasolla A, Mariano A, Menniti A, et al.
Trop Med Infect Dis
. 2024 Aug;
9(8).
PMID: 39195625
Neurocysticercosis (NCC) is caused by the larval stage of . This parasitic disease is endemic in many areas of the world and is emerging in Europe. NCC can affect different...
13.
Simone M, Lucisano G, Guerra T, Paolicelli D, Rocca M, Morra V, et al.
J Neurol
. 2024 Aug;
271(10):6782-6790.
PMID: 39179712
Background: To compare Expanded Disability Status Scale (EDSS) trajectories over time between Multiple Sclerosis (MS) groups with pediatric (POMS), adult (AOMS) and late (LOMS) onset, and between patients with and...
14.
Cruciani A, Capone F, Haggiag S, Prosperini L, Santoro F, Ruggieri S, et al.
Cereb Cortex
. 2024 Aug;
34(8.
PMID: 39172095
Aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) is an autoimmune disease characterized by suboptimal recovery from attacks and long-term disability. Experimental data suggest that AQP4 antibodies can disrupt neuroplasticity, a...
15.
Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world context
Prosperini L, Ruggieri S, Haggiag S, Tortorella C, Gasperini C
Mult Scler
. 2024 Jul;
30(10):1309-1321.
PMID: 39082635
Objective: To summarize the current evidence on relapse-associated worsening (RAW) and progression independent of relapse activity (PIRA) through a quantitative synthesis of real-world studies. Methods: Scientific databases were searched to...
16.
Filippi M, Preziosa P, Barkhof F, Ciccarelli O, Cossarizza A, De Stefano N, et al.
Brain
. 2024 Jul;
147(11):3665-3680.
PMID: 39045667
The interaction between ageing and multiple sclerosis is complex and carries significant implications for patient care. Managing multiple sclerosis effectively requires an understanding of how ageing and multiple sclerosis impact...
17.
Haggiag S, Giannelli V, Prosperini L, Cruciani A, Baiocchini A, Ruggieri S, et al.
Neurol Sci
. 2024 Jul;
45(10):5115.
PMID: 39017758
No abstract available.
18.
Ciccarelli O, Barkhof F, Calabrese M, De Stefano N, Eshaghi A, Filippi M, et al.
Neurology
. 2024 Jun;
103(1):e209444.
PMID: 38889384
Progression independent of relapse activity (PIRA), a recent concept to formalize disability accrual in multiple sclerosis (MS) independent of relapses, has gained popularity as a potential clinical trial outcome. We...
19.
Haggiag S, Giannelli V, Prosperini L, Cruciani A, Baiocchini A, Ruggieri S, et al.
Neurol Sci
. 2024 Jun;
45(10):5087-5089.
PMID: 38861049
No abstract available.
20.
Cortese R, Battaglini M, Prados F, Gentile G, Luchetti L, Bianchi A, et al.
Ann Neurol
. 2024 May;
96(2):276-288.
PMID: 38780377
Objective: To evaluate: (1) the distribution of gray matter (GM) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD), and relapsing-remitting multiple sclerosis (RRMS);...